Sun Pharmaceutical Industries Ltd

Clear tag ×

Regulatory Approval

Sun Pharmaceutical Industries Shares Jump 10% in 6 Days Since Regulatory Approval

Sun Pharmaceutical Industries Ltd receives US FDA approval for ILUMYA in adults with active psoriatic arthritis, expanding its specialty dermatology portfolio.

Sun Pharmaceutical Industries · 30 Oct 2026, 8:07 AM IST

Partnership

Sun Pharma Signs Global Licensing Deal with LIB Therapeutics for Lerodalcibep

Sun Pharmaceutical Industries · 28 Sep